Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Oct;42(10):622-637.

Xadago (Safinamide): A Monoamine Oxidase B Inhibitor for the Adjunct Treatment of Motor Symptoms in Parkinson's Disease

Martin Paspe Cruz

Xadago (Safinamide): A Monoamine Oxidase B Inhibitor for the Adjunct Treatment of Motor Symptoms in Parkinson's Disease

Martin Paspe Cruz. P T. 2017 Oct.

Abstract

Xadago (safinamide), a monoamine oxidase B inhibitor for the adjunct treatment of motor symptoms in Parkinson's disease.

PubMed Disclaimer

Conflict of interest statement

Disclosure: The author reports no commercial or financial interests in regard to this article.

Figures

Figure 1
Figure 1
Structural Formula of Safinamide
See this image and copyright information in PMC

References

    1. National Institute of Neurological Disorders and Stroke. Parkinson’s disease information page. [Accessed July 18, 2016]. Available at: www.ninds.nih.gov/Disorders/All-Disorders/Parkinsons-disease-Information....
    1. Forsaa EB, Larsen JP, Wentzel-Larsen T, et al. A 12-year population-based study of psychosis in Parkinson disease. Arch Neurol. 2010;67(8):996–1001. - PubMed
    1. Fenelon G, Alves G. Epidemiology of psychosis in Parkinson’s disease. J Neuro Sci. 2010;289(1–2):12–17. - PubMed
    1. Cummings J, Isaacson S, Mills R, et al. Pimavanserin for patients with Parkinson’s disease psychosis: a randomised, placebo-controlled phase 3 trial. Lancet. 2014;383(9916):533–540. - PubMed
    1. Factor SA, Feustel PJ, Friedman JH, et al. Longitudinal outcome of Parkinson’s disease patients with psychosis. Neurology. 2003;60(11):1756–1761. - PubMed

LinkOut - more resources